poisar

Stocks · News reference

UBS Upgrades Celestica to Buy, Raises Price Target to $430

BenzingaBenzinga Newsdesk

UBS analyst David Vogt upgrades Celestica (NYSE:CLS) from Neutral to Buy and raises the price target from $410 to $430.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading